These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3477567)

  • 1. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells.
    Rey F; Barré-Sinoussi F; Schmidtmayerova H; Chermann JC
    J Virol Methods; 1987 Jun; 16(3):239-49. PubMed ID: 3477567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
    McKeating JA; McKnight A; McIntosh K; Clapham PR; Mulder C; Weiss RA
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3327-33. PubMed ID: 2575137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus.
    Prince AM; Pascual D; Kosolapov LB; Kurokawa D; Baker L; Rubinstein P
    J Infect Dis; 1987 Aug; 156(2):268-72. PubMed ID: 3474300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals.
    Alesi DR; Ajello F; Lupo G; Vitale F; Portera M; Spadaro F; Romano N
    J Med Virol; 1989 Jan; 27(1):7-12. PubMed ID: 2784162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay.
    Langlois AJ; Matthews TJ; Weinhold KJ; Chaffee S; Hershfield M; Bolognesi DP
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):63-9. PubMed ID: 3163254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells.
    Yoshiyama H; Nakashima H; Kobayashi S; Yamamoto N
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):91-8. PubMed ID: 3284555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human retrovirus infection and immunodeficiencies. Detection and significance of virus-neutralizing antibodies.
    Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Francavilla E; Amadori A; Chieco-Bianchi L
    Antibiot Chemother (1971); 1987; 38():159-66. PubMed ID: 3662468
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV).
    Harada S; Purtilo DT; Koyanagi Y; Sonnabend J; Yamamoto N
    J Immunol Methods; 1986 Sep; 92(2):177-81. PubMed ID: 3639115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a commercial ELISA test for the diagnosis of infection by the AIDS virus, HIV, in a patient population.
    Johnson JE
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):267-71. PubMed ID: 3471372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-2 antisera cross-neutralize HIV-1.
    Weiss RA; Clapham PR; Weber JN; Whitby D; Tedder RS; O'Connor T; Chamaret S; Montagnier L
    AIDS; 1988 Apr; 2(2):95-100. PubMed ID: 3132953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.
    Nara PL; Hatch WC; Dunlop NM; Robey WG; Arthur LO; Gonda MA; Fischinger PJ
    AIDS Res Hum Retroviruses; 1987; 3(3):283-302. PubMed ID: 3481271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescence tests for HIV antibody and their value as confirmatory tests.
    van der Groen G; Vercauteren G; Piot P
    J Virol Methods; 1987 Aug; 17(1-2):35-43. PubMed ID: 3312266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel rapid micro-neutralization ELISA for the detection of neutralizing antibodies against Chandipura virus.
    Damle RG; Patil AA; Bhide VS; Pawar SD; Sapkal GN; Bondre VP
    J Virol Methods; 2017 Feb; 240():1-6. PubMed ID: 27856212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies.
    Virók DP; Eszik I; Mosolygó T; Önder K; Endrész V; Burián K
    J Virol Methods; 2017 Apr; 242():46-52. PubMed ID: 28093274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative determination of the infective activity of the human immunodeficiency virus by plaque formation using monolayer cultures].
    Nosik MN; Stepanova LG; Matsevich GR
    Vopr Virusol; 1995; 40(5):202-5. PubMed ID: 8659172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New HIV plaque titration; application to the assay of neutralizing antibody.
    Tsunetsugu-Yokota Y; Ohshima M; Naito A; Chermann JC; Shih J; Yoshikura H
    J Virol Methods; 1993 Jan; 41(1):47-57. PubMed ID: 8432763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.
    Goudsmit J; Thiriart C; Smit L; Bruck C; Gibbs CJ
    Vaccine; 1988 Jun; 6(3):229-32. PubMed ID: 3166553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.